Kao Corp. Aktie
17,75 €
Deine Einschätzung
Kao Corp. Aktie
Was spricht für und gegen Kao Corp. in den nächsten Jahren?
Pro
Kontra
Rendite von Kao Corp. im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Kao Corp. | -0,42 % | -50,00 % | -43,55 % | -52,10 % | -48,00 % | -47,43 % | -66,70 % |
| Kose Corp | -0,68 % | 7,35 % | 2,82 % | -14,12 % | 4,29 % | -67,56 % | -78,05 % |
| Pola Orbis Holdings Inc. | 1,44 % | 2,96 % | 6,11 % | -4,14 % | 0,00 % | -47,35 % | -68,41 % |
| Shiseido Co. Ltd | -0,23 % | 8,71 % | 10,06 % | -1,95 % | 21,24 % | -63,16 % | -75,65 % |
Kommentare
News
Claude responded: Alignment Healthcare's CEO Sold Shares — But the Real Risk Is Policy, Not InsidersAlignment Healthcare's CEO Sold Shares — But the Real Risk Is Policy, Not Insiders
On May 11, 2026, John E. Kao, Chief Executive Officer of Alignment Healthcare (NASDAQ:ALHC), reported the indirect sale of 298,000 shares of common stock for a total transaction value of
Alignment Healthcare Backs Q2 Outlook as Stable Costs, New Markets Lift Margin Hopes
Alignment Healthcare (NASDAQ:ALHC) executives said the company remains confident in its second-quarter outlook, citing stable medical cost
Alignment Healthcare CEO Sells $2.1 Million in Shares. Here's What Investors Should Know
John E. Kao, Chief Executive Officer of Alignment Healthcare (NASDAQ:ALHC), reported the indirect sale of 118,000 shares for a transaction value of about $2.06 million, according to a SEC Form 4





